✦ LIBER ✦

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer

✍ Scribed by Dr. Anne-Marie Cleton-Jansen; Elna W. Moerland; Net J. Kuipers-Dijkshoorn; Cees J. Cornelisse; Peter Devilee; David F. Callen; Grant R Sutherland; Bettine Hansen

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 565 KB
Volume: 9
Category: Article
ISSN: 1045-2257
DOI: 10.1002/gcc.2870090205

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Loss of heterozygosity (LOH) or allelic imbalance, the latter term referring to both loss and gain of an allele, on the long arm of chromosome 16 has been repeatedly found in cancers of, e.g., the breast and prostate. This indicates the presence of one or more tumor suppressor genes on 16q. To locate the gene(s) more precisely, a detailed allelic imbalance map of 20 polymorphic markers on this chromosome arm was made for 79 sporadic breast carcinomas. LOH of one or more markers was found in 63% of the tumors. Some had allelic imbalance on a region of 16q which failed to overlap with the LOH in other tumors. We therefore assigned two separate “smallest regions of overlap” to 16q and suggest that this chromosome arm contains at least two different tumor suppressor genes. Genes Chrom Cancer 9:101‐107 (1994).© 1994 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Identification of two distinct regions o

Identification of two distinct regions of allelic imbalance on chromosome 18q in metastatic prostate cancer

✍ Susan S. Padalecki; Dean A. Troyer; Marc F. Hansen; Tomo Saric; Barbara G. Schne 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB 👁 2 views

Like most cancers, prostate cancer (CaP) is believed to be the result of the accumulation of genetic alterations within cells. Previous studies have implicated numerous chromosomal regions with elevated rates of allelic imbalance (AI), using mostly primary CaPs with an unknown disease outcome. These

Association of allelic losses on human c

Association of allelic losses on human chromosomal arms 11q and 16q in sporadic breast cancer

✍ Rita K. Schmutzler; Rolf Fimmers; Erhard Bierhoff; Barbara Lohmar; Anke Homann; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 517 KB

Breast-carcinoma development presumably results from multiple mutational events in tumor-associated genes. Certain results indicate that some tumor-suppressor genes may combine their pathogenetic potential to synergistically promote tumor growth. In an effort to identify such mechanisms in breast tu

High frequency of allelic imbalance at c

High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: Correlation with high pgr and low s phase

✍ Sigurlaug Skirnisdottir; Gudny Eiriksdottir; Trausti Baldursson; Rosa B. Barkard 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 668 KB

The loss of genetic material from a specific chromosome region in tumors suggests the presence of tumor-suppressor genes. Loss of heterozygosity (LOH) or allelic imbalance (Al) on the long arm of chromosome 16 is a known event in sporadic breast cancer. To locate the commonly deleted regions, and th

Allele loss on chromosome arm 6q and fin

Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer

✍ Inez E. Cooke; Andrew N. Shelling; Valérie G. Le Meuth; F. Mark L. Charnock; Tri 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

Genetic changes have been shown to be important in determining the multistep progression of cancer. Allele loss studies and karyotypic analysis of epithelial ovarian tumours have indicated the presence of putative w m u r suppressor genes on chromosomes 6, I I, I 3, 17, I8,22, and X. We have focused

A widely expressed transcription factor

A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers

✍ Galina N. Filippova; Annika Lindblom; Linda J. Meincke; Elena M. Klenova; Paul E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

The cellular protooncogene MYC encodes a nuclear transcription factor that is involved in regulating important cellular functions, including cell cycle progression, differentiation, and apoptosis. Dysregulated MYC expression appears critical to the development of various types of malignancies, and t